ATE557101T1 - Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum - Google Patents

Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum

Info

Publication number
ATE557101T1
ATE557101T1 AT05723099T AT05723099T ATE557101T1 AT E557101 T1 ATE557101 T1 AT E557101T1 AT 05723099 T AT05723099 T AT 05723099T AT 05723099 T AT05723099 T AT 05723099T AT E557101 T1 ATE557101 T1 AT E557101T1
Authority
AT
Austria
Prior art keywords
methods
compositions
subject
tolerant phenotype
transplantation
Prior art date
Application number
AT05723099T
Other languages
English (en)
Inventor
Elaine Mansfield
Minnie Sarwal
Sophie Brouard
Jean-Paul Soulilou
Original Assignee
Univ Leland Stanford Junior
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Inst Nat Sante Rech Med filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE557101T1 publication Critical patent/ATE557101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
AT05723099T 2004-01-21 2005-01-20 Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum ATE557101T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53843904P 2004-01-21 2004-01-21
US57147104P 2004-05-14 2004-05-14
PCT/US2005/004799 WO2005070086A2 (en) 2004-01-21 2005-01-20 Methods and compositions for determining a graft tolerant phenotype in a subject

Publications (1)

Publication Number Publication Date
ATE557101T1 true ATE557101T1 (de) 2012-05-15

Family

ID=34811352

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05723099T ATE557101T1 (de) 2004-01-21 2005-01-20 Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum

Country Status (5)

Country Link
US (2) US8932808B1 (de)
EP (1) EP1718768B1 (de)
AT (1) ATE557101T1 (de)
CA (2) CA2553551C (de)
WO (1) WO2005070086A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
EP2604703B1 (de) 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate
EP2029769A1 (de) 2006-05-25 2009-03-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur diagnose und behandlung von transplantatabstossung und entzündungsleiden
US20080233573A1 (en) * 2006-08-28 2008-09-25 Kathleen Storm Gene expression profiling for identification, monitoring and treatment of transplant rejection
US20080131441A1 (en) * 2006-09-26 2008-06-05 Manikkam Suthanthiran Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
EP1990425A1 (de) * 2007-05-10 2008-11-12 Tcland R Diagnose von Immuntransplantatstoleranz
EP2088205A1 (de) 2008-02-11 2009-08-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) PSMB10: Diagnosemarker und therapeutisches Target für chronische Abstoßung
EP2631301B1 (de) 2008-08-18 2017-10-11 The Board of Trustees of the Leland Stanford Junior University Verfahren zur Bestimmung eines transplantattoleranten Phänotyps bei einer Person
EP2368113A1 (de) * 2008-12-19 2011-09-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarker zur diagnose des nieren-allotransplantat- und nierenstatus
ES2492498T3 (es) * 2009-01-15 2014-09-09 The Board Of Trustees Of The Leland Stanford Junior University Panel de biomarcadores para el diagnóstico y la predicción de rechazo de injerto
US9290813B2 (en) 2009-12-02 2016-03-22 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
US9535075B2 (en) 2010-03-25 2017-01-03 The Board Of Trustees Of The Leland Stanford Junior University Protein and gene biomarkers for rejection of organ transplants
US8962261B2 (en) 2011-04-06 2015-02-24 The Board Of Trustees Of The Leland Stanford Junior University Autoantibody biomarkers for IGA nephropathy
WO2014036444A1 (en) * 2012-08-30 2014-03-06 Abbott Laboratories Prame detection assays
JP2017530356A (ja) 2014-09-26 2017-10-12 ソマロジック, インコーポレイテッドSomaLogic, Inc. 心血管系のリスクイベントの予測及びその使用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US20030104371A1 (en) 1997-09-24 2003-06-05 Strom Terry B. Methods of evaluating transplant rejection
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6429024B1 (en) 1998-03-31 2002-08-06 Asahi Kasei Kabushiki Kaisha Test method for IgA nephropathy
WO2002092124A1 (en) 2001-05-11 2002-11-21 Wyeth Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7687530B2 (en) 2002-11-21 2010-03-30 Genzyme Corporation Inhibition of chronic tissue transplant rejection
CA2516013C (en) 2003-02-14 2014-05-13 Beth Israel Deaconess Medical Center, Inc. Predicting graft rejection
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
CA2529759A1 (en) 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US20070111210A1 (en) 2003-12-03 2007-05-17 Marc Bigaud Biomarkers for graft rejection
EP1734952A1 (de) 2004-04-08 2006-12-27 Novartis AG Proteinkinase-c-hemmer zur behandlung von autoimmunerkrankungen und transplantat-abstossung
US7820382B2 (en) 2004-08-03 2010-10-26 Bauer A Robert Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation
EP2604703B1 (de) * 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate
US7666596B2 (en) 2005-05-23 2010-02-23 University Of Alberta Tissue rejection
EP1731620A1 (de) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methode zur Diagnose von Immun-Transplantatstoleranz
US8278038B2 (en) 2005-06-08 2012-10-02 Millennium Pharmaceuticals, Inc. Methods for the identification, assessment, and treatment of patients with cancer therapy
WO2007050588A2 (en) 2005-10-25 2007-05-03 Renovar Incorporated Systems and methods for characterizing conditions of organs for transplantation
BRPI0706967A2 (pt) 2006-02-06 2011-04-12 Rappaport Family Inst For Res método e kit para diagnosticar dmt1
GB0605217D0 (en) 2006-03-15 2006-04-26 Novartis Ag Method and compositions for assessing acute rejection
GB0607943D0 (en) 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
JP5171812B2 (ja) 2006-04-27 2013-03-27 ユニベルシテ ドゥ モントリオール 移植片対宿主病のリスクの評価および低減
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
WO2008009132A1 (en) 2006-07-21 2008-01-24 The Governors Of The University Of Alberta Tissue rejection
US20080233573A1 (en) 2006-08-28 2008-09-25 Kathleen Storm Gene expression profiling for identification, monitoring and treatment of transplant rejection
WO2009143624A1 (en) 2008-05-30 2009-12-03 The University Of British Columbia Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling
US8426142B2 (en) 2008-06-02 2013-04-23 Eisai R&D Management Co., Ltd. IgA nephropathy testing method and test kit
EP2631301B1 (de) 2008-08-18 2017-10-11 The Board of Trustees of the Leland Stanford Junior University Verfahren zur Bestimmung eines transplantattoleranten Phänotyps bei einer Person
KR100928403B1 (ko) 2008-10-01 2009-11-26 경북대학교 산학협력단 티지비엠 신증의 진단용 조성물 및 키트
WO2011142901A1 (en) 2010-05-13 2011-11-17 University Of Medicine And Dentistry Of New Jersey Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease

Also Published As

Publication number Publication date
WO2005070086A3 (en) 2006-09-14
CA2553551A1 (en) 2005-08-04
US20140206566A1 (en) 2014-07-24
CA2553551C (en) 2020-12-15
WO2005070086A2 (en) 2005-08-04
CA2957704A1 (en) 2005-08-04
EP1718768A2 (de) 2006-11-08
EP1718768A4 (de) 2007-10-17
EP1718768B1 (de) 2012-05-09
US8932808B1 (en) 2015-01-13

Similar Documents

Publication Publication Date Title
ATE557101T1 (de) Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum
Miao et al. ImmuCellAI: a unique method for comprehensive T‐cell subsets abundance prediction and its application in cancer immunotherapy
Corbin et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
NO20074389L (no) Bestemmelse av respondere til kjemoterapi
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
WO2006099421A3 (en) Methods and compositions for evaluating graft survival in a solid organ transplant recipient
MX2009004463A (es) Ensayo para anticuerpos de troponina cardiaca.
ATE469656T1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
ATE456801T1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a- komplexe in einer blutprobe
Zhong et al. Correlation between imatinib trough concentration and efficacy in Chinese chronic myelocytic leukemia patients
Park et al. Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia
WO2011133770A3 (en) Salivary protein markers for detection of breast cancer
Jo et al. Impact of mouse contamination in genomic profiling of patient-derived models and best practice for robust analysis
Perez‐Lamarque et al. Analysing diversification dynamics using barcoding data: the case of an obligate mycorrhizal symbiont
WO2005121366A8 (ja) 遺伝子マーカー及びその利用
MX2009006744A (es) Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
Ilhan et al. Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia
DE602005011203D1 (de) Verfahren und Zusammensetzungen zur Charakterisierung eines Redox-Reagenz-System Enzyms
Piano Mortari et al. Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
WO2007078835A3 (en) Biomarker isolation and use thereof to characterize physiological state
WO2008147206A3 (en) Means and methods for classifying samples of multiple sclerosis patients
Lovell et al. Cryptic speciation in the Warbling Vireo (Vireo gilvus)
GB0617116D0 (en) Method of diagnosis